We are live on
!
Find out more
IB
Intrust Bank Portfolio holdings
AUM
$1.35B
Turnover
12.1%
1-Year Est. Return
37.16%
This Fund
S&P 500
This Quarter
Est. Return
-14.49%
1 Year Est. Return
+37.16%
3 Year Est. Return
+102.36%
5 Year Est. Return
+128.73%
10 Year Est. Return
+460.32%
AUM
$692M
AUM Growth
-$98.5M
(-12%)
Cap. Flow
+$27.7M
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
39.83%
Holding
410
New
29
Increased
158
Reduced
183
Closed
27
Avg Time Held
4.5
years
Top 10 Avg Time Held
2.9
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$23M |
| 2 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$9.89M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$5.22M |
| 4 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$3.96M |
| 5 |
JPMorgan US Momentum Factor ETF
JMOM
|
+$1.92M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.82M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$4.6M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$2.18M |
| 4 |
Apple
AAPL
|
+$1.97M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.54% |
| 2 | Technology | 12.77% |
| 3 | Healthcare | 10.62% |
| 4 | Financials | 7.83% |
| 5 | Industrials | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Idexx Laboratories
IDXX
$43.1B
| $704K | 0.1% |
2,005
-247
| -11% | -$101K |
2015 Q1
29 quarters
|
|
177
JPMorgan US Value Factor ETF
JVAL
$1.01B
| $704K | 0.1% |
21,927
+9,198
| +72% | +$320K |
2020 Q3
7 quarters
|
|
|
FRC
178
DELISTED
First Republic Bank
FRC
| $703K | 0.1% |
4,876
-645
| -12% | -$96.7K |
2017 Q4
18 quarters
|
|
179
Steris
STE
$21.9B
| $694K | 0.1% |
3,363
-477
| -12% | -$108K |
2018 Q2
16 quarters
|
|
180
Skyworks Solutions
SWKS
$18.6B
| $689K | 0.1% |
7,440
-1,578
| -17% | -$170K |
2018 Q3
15 quarters
|
|
181
Cintas
CTAS
$84.6B
| $685K | 0.1% |
7,336
-412
| -5% | -$40.1K |
2016 Q2
24 quarters
|
|
182
Air Products & Chemicals
APD
$66B
| $684K | 0.1% |
2,845
+551
| +24% | +$134K |
2016 Q1
25 quarters
|
|
183
Medtronic
MDT
$122B
| $681K | 0.1% |
7,588
-1,478
| -16% | -$150K |
2014 Q4
30 quarters
|
|
184
Standard Motor Products
SMP
$830M
| $680K | 0.1% |
15,114
+1,932
| +15% | +$80.3K |
2021 Q1
5 quarters
|
|
185
Qualys
QLYS
$6.66B
| $678K | 0.1% |
5,376
-898
| -14% | -$118K |
2018 Q3
15 quarters
|
|
186
Novartis
NVS
$286B
| $672K | 0.1% |
7,953
+1,303
| +20% | +$114K |
2020 Q4
6 quarters
|
|
187
Labcorp
LH
$26.4B
| $671K | 0.1% |
3,337
-487
| -13% | -$104K |
2014 Q2
32 quarters
|
|
188
Kimberly-Clark
KMB
$34.6B
| $667K | 0.1% |
4,937
+996
| +25% | +$131K |
2013 Q2
36 quarters
|
|
189
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.3B
| $663K | 0.1% |
10,275
| – | – |
2016 Q4
22 quarters
|
|
190
CSX Corp
CSX
$90.2B
| $658K | 0.1% |
22,648
-1,201
| -5% | -$39.1K |
2018 Q2
16 quarters
|
|
191
Eastman Chemical
EMN
$7.3B
| $657K | 0.1% |
7,314
-325
| -4% | -$33.6K |
2016 Q2
24 quarters
|
|
192
Citigroup
C
$207B
| $650K | 0.09% |
14,121
-2,787
| -16% | -$139K |
2013 Q2
36 quarters
|
|
193
Blackrock
BLK
$174B
| $647K | 0.09% |
1,063
+196
| +23% | +$128K |
2020 Q4
6 quarters
|
|
194
Keysight
KEYS
$58.2B
| $633K | 0.09% |
4,589
-608
| -12% | -$86.5K |
2018 Q4
14 quarters
|
|
195
Toyota
TM
$226B
| $631K | 0.09% |
4,089
+1,363
| +50% | +$225K |
2021 Q2
4 quarters
|
|
196
Dominion Energy
D
$55.3B
| $628K | 0.09% |
7,868
-544
| -6% | -$44.9K |
2013 Q2
36 quarters
|
|
197
Constellation Energy
CEG
$97.4B
| $625K | 0.09% |
10,918
+3,158
| +41% | +$190K |
2022 Q1
1 quarter
|
|
198
MasTec
MTZ
$15.4B
| $615K | 0.09% |
8,594
+249
| +3% | +$19.4K |
2020 Q2
8 quarters
|
|
199
Vertex Pharmaceuticals
VRTX
$129B
| $611K | 0.09% |
2,169
+450
| +26% | +$120K |
2021 Q4
2 quarters
|
|
200
Charles River Laboratories
CRL
$14.6B
| $609K | 0.09% |
2,846
-201
| -7% | -$49.1K |
2018 Q2
16 quarters
|
|
Similar funds
CC
HVCM
RI
RCYC
KB
NC
PP
OPFM
Intrust Bank's Q2 2022 Portfolio in Review
As of Q2 2022, Intrust Bank held 410 positions worth $692M, down 12% from $790M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Intrust Bank deployed $27.7M of net new capital in Q2 2022, opening 29 new positions and adding to 158 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 465,760 shares worth $21.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 37% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $4.82M trimmed.
- Intrust Bank's largest Q2 2022 buy was iShares Core S&P Mid-Cap ETF: 465,760 shares worth $21.1M.
- Intrust Bank added most to Vanguard FTSE Developed Markets ETF in Q2 2022, an estimated $5.22M increase.
- Intrust Bank's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $4.82M.
- Intrust Bank fully exited Akamai in Q2 2022, selling an estimated $585K.
- Intrust Bank's ten largest holdings make up 40% of its $692M portfolio in Q2 2022.
- Intrust Bank opened 29 new positions and closed 27 in Q2 2022.
- Intrust Bank's portfolio value fell 12% quarter-over-quarter to $692M.
Based on Intrust Bank's 13F filing for Q2 2022, filed 16 Aug 2022.